ABBOTT LABORATORIES T.ABT

Primary Symbol: ABT

Healthcare Medical Devices

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

NYSE:ABT - Post by User

ABBOTT LABORATORIES

Bullboard Posts

Comment by beckalodeonon Jan 30, 2008 9:04pm

502 Views

Post# 14293650

RE: RBC Report - Reiterates $23 Target

Nope; in fact, you caught something. That's a typo in the report, obviously accidentally left in from the pre-split days. It's funny, though - reading that, I'm reminded how recently ABT was trading at (a split-adjusted) $17.50. It will be loved again. - beck ============================== Did I miss something here? "Despite the rapid increase in the stock over the past 12 months from less than $6 a year ago to more than $35 today,"...something seems wrong with this to me.

Bullboard Posts

The Market Online’s Weekly Cannabis Report – July 5, 2024